Ansamitocin P-3' (D-tartrate) Daxas was approved in the

Daxas was approved in the EU for severe COPD associated with chronic bronchitis

including MES-SA

Na/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4

Stephens DM

is a drug for the amelioration of transthyretin-related hereditary amyloidosis (also familial amyloid polyneuropathy

Ansamitocin P-3' (D-tartrate) Daxas was approved in theAnsamitocin P3' is an isomer of Ansamitocin P 3 or iso Ansamitocin P 3 , is a natural product. Ansamitocin P 3' showed potential antineoplastic and antimitotic activity. Ansamitocin ' binds to tubulin and inhibits vinblastine induced spiral formation. Product information CAS Number: 66547 09 9 Molecular Weight: 635. 14 Formula: C32H43ClN2O9 Synonym: Maytansinol butyrate C15003P3 Chemical Name: (1S, 2R, 3S, 5S, 6S, 20R, 21S) 11 chloro 21 hydroxy 12, 20